Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation

Sandra B Haudek1, Damon Gupta, Oliver Dewald

  • 1DeBakey Heart Center, Baylor College of Medicine and The Methodist Hospital, One Baylor Plaza F620, Houston TX 77030, USA. shaudek@bcm.tmc.edu

Insights

Rho-associated kinase-1 (ROCK-1) is crucial for monocyte differentiation into cardiac fibroblasts, a key driver of fibrosis in heart disease. Inhibiting ROCK-1 reduces fibroblast formation without affecting cell migration, offering a potential therapeutic target.

Area of Science:

  • Cardiovascular Research
  • Fibrosis Mechanisms
  • Cell Biology

Background:

  • Fibrosis in ischaemic/reperfusion cardiomyopathy (I/RC) involves CD34+/CD45+ fibroblasts from monocytic precursors.
  • Monocyte differentiation into fibroblasts occurs after transendothelial migration (TEM) induced by monocyte chemoattractant protein 1 (MCP-1).
  • Rho-associated kinase-1 (ROCK-1) is implicated in fibrosis and leukocyte TEM.

Purpose of the Study:

  • To investigate the role of ROCK-1 in I/RC-induced cardiac fibrosis.
  • To determine if ROCK-1 influences monocyte TEM or subsequent fibroblast differentiation.

Main Methods:

  • Mice with genetic deletion of ROCK-1 were subjected to I/RC.
  • In vitro assays assessed human peripheral blood mononuclear cell (PBMC) migration and differentiation after ROCK-1 silencing.
  • Quantification of alpha-smooth muscle actin+ fibroblasts and CD34+/CD45+ precursors in cardiac tissue.

Main Results:

  • ROCK-1(-/-) mice showed no significant fibrosis or cardiac dysfunction post-I/RC.
  • ROCK-1 deletion markedly reduced I/RC-induced fibroblasts and precursor cells.
  • In vitro, ROCK-1 silencing reduced monocyte-to-fibroblast differentiation by over 20-fold but did not inhibit TEM.

Conclusions:

  • ROCK-1 plays a critical role in the differentiation of monocytes into cardiac fibroblasts.
  • ROCK-1 is not essential for monocyte transendothelial migration.
  • Targeting ROCK-1 may offer a strategy to mitigate non-adaptive cardiac fibrosis.
Abstract

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...